UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	September 8, 2023 4:00 P.M.

Form:	S-3
CIK: 0001806310 Company Name: Taysha Gene Therapies, Inc. File Number: 333-274264